Cargando…
Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis
BACKGROUND: Sickle cell disease (SCD) is a complex genetic disorder that manifests in infancy and progresses throughout life in the form of acute and chronic complications. As the upfront costs of potentially curative, genetic therapies will likely be high, an assessment and comprehensive characteri...
Autores principales: | Baldwin, Zachary, Jiao, Boshen, Basu, Anirban, Roth, Joshua, Bender, M. A., Elsisi, Zizi, Johnson, Kate M., Cousin, Emma, Ramsey, Scott D., Devine, Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283624/ https://www.ncbi.nlm.nih.gov/pubmed/35471578 http://dx.doi.org/10.1007/s41669-022-00330-w |
Ejemplares similares
-
Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance
por: Johnson, Kate M., et al.
Publicado: (2022) -
Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease
por: Johnson, Kate M., et al.
Publicado: (2022) -
Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries
por: Jiao, Boshen, et al.
Publicado: (2023) -
Prevalence of comorbidities associated with sickle cell disease among non-elderly individuals with commercial insurance–A retrospective cohort study
por: Ramsey, Scott D., et al.
Publicado: (2022) -
A Framework for a Health Economic Evaluation Model for Patients with Sickle Cell Disease to Estimate the Value of New Treatments in the United States of America
por: Winn, Aaron, et al.
Publicado: (2023)